ORIC
ORIC Pharmaceuticals·NASDAQ
--
--(--)
--
--(--)
ORIC fundamentals
ORIC Pharmaceuticals (ORIC) released its earnings on Nov 13, 2025: revenue was 0 (YoY --), met estimates; EPS was -0.33 (YoY +32.65%), beat estimates.
Revenue / YoY
0
--
EPS / YoY
-0.33
+32.65%
Report date
Nov 13, 2025
EPS
Actual | -4.46 | -0.51 | -0.84 | -0.84 | -0.45 | -0.57 | -0.47 | -0.58 | -0.59 | -0.51 | -0.63 | -0.52 | -0.53 | -0.5 | -0.44 | -0.49 | -0.37 | -0.45 | -0.49 | -0.51 | -0.42 | -0.47 | -0.33 |
Forecast | -0.3427 | -0.3962 | -0.3947 | -0.4108 | -0.4825 | -0.4924 | -0.5824 | -0.5654 | -0.5681 | -0.6001 | -0.553 | -0.548 | -0.5404 | -0.5689 | -0.4622 | -0.4775 | -0.4292 | -0.4124 | -0.4782 | -0.5004 | -0.5111 | -0.443 | -0.4052 |
Surprise | -1201.43% | -28.72% | -112.82% | -104.48% | +6.74% | -15.76% | +19.30% | -2.58% | -3.85% | +15.01% | -13.92% | +5.11% | +1.92% | +12.11% | +4.80% | -2.62% | +13.79% | -9.12% | -2.47% | -1.92% | +17.82% | -6.09% | +18.56% |
Revenue
Actual | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Forecast | -- | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings Call
You can ask Aime
What guidance did ORIC Pharmaceuticals's management provide for the next earnings period?What is ORIC Pharmaceuticals's latest dividend and current dividend yield?Did ORIC Pharmaceuticals beat or miss consensus estimates last quarter?What factors drove the changes in ORIC Pharmaceuticals's revenue and profit?What were the key takeaways from ORIC Pharmaceuticals’s earnings call?What is the revenue and EPS growth rate for ORIC Pharmaceuticals year over year?What does ORIC Pharmaceuticals do and what are its main business segments?What is ORIC Pharmaceuticals's gross profit margin?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
